NSE filing, NSE: TIRUMALCHM. Summary written from the filing by ALFA Finder's alert engine.
Thirumalai Chemicals Ltd: key numbers
- Share price
- ₹119.82
- Market cap
- ₹1,444 Cr
- Revenue (annual)
- ₹1,736 Cr
- Net profit (annual)
- ₹-167.9 Cr
- P/E (TTM)
- -9.5×Sector 34.1×
- Promoter holding
- 37.13%+0.00% QoQ
- FII holding
- 1.39%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Thirumalai Chemicals Ltd
All →Thirumalai Chemicals Promoter Reclassification
Thirumalai Chemicals received requests from two promoter group members, Narayan Santhanam and Deepa Ajay, to reclassify 100,000 shares (0.08%) as public. The board will consider the requests at its next meeting.
Thirumalai Chemicals Legal & Regulatory
Thirumalai Chemicals received a customs audit observation demanding Rs. 0.2452 Crore for alleged ineligible export benefits. The company contests the demand as erroneous and insignificant.
- Value
- ₹0.25 Cr
- From
- Assistant Commissioner, Office of Commissioner of Customs Audit Chennai
Thirumalai Chemicals Other Announcement
The company has filed its quarterly shareholding pattern under Regulation 31 for the period ended September 30, 2026.
Thirumalai Chemicals Legal & Regulatory
Thirumalai Chemicals received a tax show cause notice for Rs. 17.31 Crore regarding GST discrepancies for FY 2023-24. The company intends to contest the demand.
- Value
- ₹17.31 Cr
Thirumalai Chemicals Merger & Restructuring
Thirumalai Chemicals Limited sold 9,50,000 equity shares in Ultramarine & Pigments Limited through the open market. This transaction reduced its holding from 9.38% to 6.13%.
Thirumalai Chemicals Legal & Regulatory
Thirumalai Chemicals received a GST show cause notice regarding tax scrutiny for FY 2022-2023. The total demand amount is Rs. 13.52 Lakhs.
- Value
- ₹0.14 Cr
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.